- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UK-06-0014043

Parrish Pharmaceutical Private Limited
About Parrish Pharmaceutical Private Limited
Data last updated:
Parrish Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 May 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2022PTC398795. Its GSTIN is 05AAMCP9240N1ZU (Uttarakhand).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.8 Cr. It is led by directors including Ravikant and Priyanka.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 33 F/F Hari Nagar Extn Gali No. 2 Badarpur, Delhi, India – 110044.
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.95 Cr on record.
Parrish Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0014043). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Parrish Pharmaceutical
Contact details
Parrish Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 33 F/F Hari Nagar Extn Gali No. 2 Badarpur, Delhi, India – 110044
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Parrish Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Parrish Pharmaceutical Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Parrish Pharmaceutical Private Limited, buy the company report.
Board of directors of Parrish Pharmaceutical Private Limited
Parrish Pharmaceutical has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravikant Also directs: Ballyfin Hotel and Resorts LLP | Director | 16 Jun 2022 | 4 Years 5 Months | Current |
| Priyanka | Director | 23 May 2022 | 4 Years 5 Months | Current |
| Rohit Bhardwaj | Additional Director | 01 Oct 2025 | 1 Years 1 Months | Current |
Auditor
Parrish Pharmaceutical Private Limited is audited by RISHABH GARG & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RISHABH GARG & CO. | FY 2024 | 018065C |
Shareholding
The shareholding of Parrish Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Parrish Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Mar 2023 | 100698277 | State Bank of India | ₹4.95 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Parrish Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parrish Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Parrish Pharmaceutical Private Limited has a workforce of 16 employees on its EPFO records as of Mar 2025, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 16 |
GST
Parrish Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAMCP9240N1ZU | Uttarakhand | Active | 12 Dec 2022 |
To see the full GST registrations and return filing status of Parrish Pharmaceutical Private Limited, buy the company report.
Recent activity
Parrish Pharmaceutical Private Limited has 8 board changes on record since 2022: 4 appointments and 4 cessations. The latest: Rohit Bhardwaj was appointed as Additional Director on 01 Oct 2025.
Frequently asked questions
Parrish Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 May 2022 (4+ years old) and is registered under CIN U24239DL2022PTC398795.
Parrish Pharmaceutical has 3 current directors:
- Ravikant - Director
- Priyanka - Director
- Rohit Bhardwaj - Additional Director
The latest financial statements of Parrish Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Parrish Pharmaceutical is 05AAMCP9240N1ZU, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Parrish Pharmaceutical is U24239DL2022PTC398795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parrish Pharmaceutical was incorporated on 23 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Rohit Bhardwaj was appointed as Additional Director on 01 Oct 2025. Sunil Kumar ceased to be Director on 02 Dec 2024. Varun Kumar Thakur ceased to be Director on 02 Dec 2024. Parrish Pharmaceutical has 8 board changes on record in total.
Yes, Parrish Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0014043).
The registered office of Parrish Pharmaceutical is at E – 33 FF Hari Nagar Extn Gali No. 2 Badarpur, Delhi, India – 110044.
Parrish Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

